BETA BIONICS INC (BBNX) Stock Income Statement
NASDAQ:BBNX - Nasdaq - US08659B1026 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|
| Revenue | 65.12M | 11.99M | 179.00K | |||
| Cost Of Goods | 29.24M | 5.69M | N/A | |||
| Gross Profit | 35.89M | 6.31M | N/A | |||
| Operating Expenses | 81.14M | 42.16M | 66.02M | |||
| Research and Development | 26.18M | 17.94M | 31.43M | |||
| Selling, General, and Administrative Expenses | 54.95M | 24.21M | 34.59M | |||
| Operating Income | -45.25M | -35.85M | -65.84M | |||
| Interest Income/Expense | 3.91M | 1.71M | 182.00K | |||
| Other Income/Expense | -13.41M | -9.96M | 911.00K | |||
| Income Before Taxes | -54.76M | -44.10M | -64.75M | |||
| Net Income | -54.76M | -44.10M | -64.75M | |||
| EBITDA | -42.97M | -33.76M | -63.76M | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -1.28 | -1.03 | -1.51 | |||
| Statistics | ||||||
| Gross Profit Margin | 55.11% | 52.59% | N/A | |||
| Profit Margin | -84.08% | -367.64% | -36173.74% | |||
| Operating Profit Margin | -69.48% | -298.87% | -36784.36% | |||
All data in USD